David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
CALL
Chegg
CHGG
$89.7M
| $19.7M | 0.03% |
550,000
| – | – |
|
|
602
CALL
Pfizer
PFE
$159B
| $19.7M | 0.03% |
635,246
-1,178,793
| -65% | -$40.2M |
|
|
XLRN
603
DELISTED
Acceleron Pharma
XLRN
| $19.7M | 0.03% |
+218,866
| New | +$17M |
|
604
The Mosaic Company
MOS
$7.66B
| $19.6M | 0.03% |
1,815,801
-1,927,619
| -51% | -$32.7M |
|
|
NEE.PRP
605
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $19.6M | 0.03% |
+450,000
| New | +$18.9M |
|
606
Green Dot
GDOT
$767M
| $19.6M | 0.03% |
771,892
-638,822
| -45% | -$18.4M |
|
607
CALL
Chevron
CVX
$396B
| $19.6M | 0.03% |
270,400
-453,900
| -63% | -$44.9M |
|
608
SiteOne Landscape Supply
SITE
$4.17B
| $19.5M | 0.03% |
265,301
+32,802
| +14% | +$3M |
|
609
Arrowhead Research
ARWR
$12.2B
| $19.5M | 0.03% |
676,121
-16,774
| -2% | -$676K |
|
610
PBF Energy
PBF
$8.25B
| $19.4M | 0.03% |
2,743,569
+1,969,890
| +255% | +$44.2M |
|
611
PUT
Paycom
PAYC
$10.4B
| $19.3M | 0.03% |
95,600
+39,700
| +71% | +$10.9M |
|
612
Vanguard Global ex-US Real Estate ETF
VNQI
$3.53B
| $19.3M | 0.03% |
449,233
-800,683
| -64% | -$43.1M |
|
613
Freshpet
FRPT
$3.65B
| $19.2M | 0.03% |
300,690
+38,779
| +15% | +$2.49M |
|
614
CALL
Blackrock
BLK
$181B
| $19.2M | 0.03% |
43,600
-23,100
| -35% | -$11.4M |
|
615
PUT
PepsiCo
PEP
$198B
| $19.2M | 0.03% |
159,600
+36,700
| +30% | +$4.96M |
|
616
Chubb
CB
$134B
| $19.1M | 0.03% |
171,063
+169,319
| +9,709% | +$24.3M |
|
|
MGLN
617
DELISTED
Magellan Health Services, Inc.
MGLN
| $19.1M | 0.03% |
396,167
-7,494
| -2% | -$482K |
|
618
CALL
Berkshire Hathaway Class B
BRK.B
$1.07T
| $18.9M | 0.03% |
103,500
-192,000
| -65% | -$40.8M |
|
619
Avnet
AVT
$7.1B
| $18.9M | 0.03% |
753,063
-69,872
| -8% | -$2.38M |
|
|
CFXA
620
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $18.9M | 0.03% |
205,000
-10,000
| -5% | -$1.39M |
|
621
Regeneron Pharmaceuticals
REGN
$85B
| $18.8M | 0.03% |
38,588
-41,893
| -52% | -$17.3M |
|
|
CCI.PRA
622
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $18.8M | 0.03% |
14,500
| – | – |
|
623
CALL
AbbVie
ABBV
$467B
| $18.8M | 0.03% |
246,700
-616,300
| -71% | -$52.5M |
|
624
CALL
General Motors
GM
$75.6B
| $18.8M | 0.03% |
903,300
-197,900
| -18% | -$6.04M |
|
|
625
PUT
Biogen
BIIB
$31.8B
| $18.8M | 0.03% |
59,300
-78,400
| -57% | -$23.8M |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.